Gary Lieberman analyst WELLS FARGO

Currently out of the existing stock ratings of Gary Lieberman, 7 are a HOLD (70%), 2 are a SELL (20%), 1 are a BUY (10%).

Gary Lieberman

Work Performance Price Targets & Ratings Chart

Analyst Gary Lieberman, currently employed at WELLS FARGO, carries an average stock price target met ratio of 100% that have a potential upside of 2.73% achieved within 62 days.

Gary Lieberman’s has documented 14 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on DGX, Quest Diagnostics at 20-Oct-2017.

Wall Street Analyst Gary Lieberman

Analyst best performing recommendations are on DGX (QUEST DIAGNOSTICS).
The best stock recommendation documented was for DGX (QUEST DIAGNOSTICS) at 10/12/2017. The price target of $88 was fulfilled within 49 days with a profit of $6.07 (7.41%) receiving and performance score of 1.51.

Average potential price target upside

DGX Quest Diagnostics THC Tenet Healthcare

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Feb-2026

$260

$32.94 (14.51%)

$250

Hold Since 02-Feb-2018

$260

$32.94 (14.51%)

$250

17 days ago
(21-Sep-2026)

22/24 (91.67%)

$15.12 (6.17%)

352

Hold Since 22-Apr-2022

$245

$17.94 (7.90%)

$220

1 months ago
(08-Sep-2026)

20/20 (100%)

$9.5 (4.03%)

276

Hold Since 30-May-2024

$250

$22.94 (10.10%)

$190

2 months 10 days ago
(28-Jul-2026)

5/6 (83.33%)

$14.06 (5.96%)

245

Buy Since 26-Apr-2017

$260

$32.94 (14.51%)

$235

2 months 14 days ago
(24-Jul-2026)

30/31 (96.77%)

$32.14 (14.11%)

557

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Gary Lieberman?

On 2013
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?